Positive efficacy and safety data were observed at 3 months after a single injection of K8 in this study conducted at the University of Kentucky.

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA ... reviewed at the CHMP's October meeting, but ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay ... on Izervay for the management of a chronic, progressive disease that can lead to irreversible ...

for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). As a result, IZERVAY is now approved without a limitation on duration of dosing—providing ...

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...

It is a progressive neurological disease that affects ... there was a greater degree of atrophy or hypertrophy not only in the movement-related structures but also in other cortical areas.

Do we believe the Hamas spokesperson who said that rape is forbidden, therefore it couldn’t have possibly happened on October 7th? Or do we believe the women whose bodies tell us how they spent ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long alternative to intravitreal injections.

Nearly all adults with relapsing forms of multiple sclerosis (MS) said they are highly satisfied with the Sensoready autoinjector pen to self-administer Kesimpta (ofatumumab), according to a ...